D.E. Shaw & Co’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,313,099
Closed -$4.14M 3025
2020
Q3
$4.14M Sell
1,313,099
-520,213
-28% -$1.64M ﹤0.01% 1294
2020
Q2
$5.34M Sell
1,833,312
-71,741
-4% -$209K 0.01% 1145
2020
Q1
$5.37M Buy
1,905,053
+271,402
+17% +$765K 0.01% 1034
2019
Q4
$5.3M Sell
1,633,651
-522,516
-24% -$1.7M 0.01% 1150
2019
Q3
$4.66M Buy
2,156,167
+205,719
+11% +$444K 0.01% 1171
2019
Q2
$6.13M Sell
1,950,448
-59,001
-3% -$185K 0.01% 1074
2019
Q1
$7.48M Sell
2,009,449
-358,505
-15% -$1.33M 0.01% 968
2018
Q4
$6.87M Buy
2,367,954
+258,841
+12% +$751K 0.01% 977
2018
Q3
$5.55M Sell
2,109,113
-228,028
-10% -$600K 0.01% 1086
2018
Q2
$5.47M Sell
2,337,141
-85,082
-4% -$199K 0.01% 1083
2018
Q1
$7.12M Buy
2,422,223
+406,870
+20% +$1.2M 0.01% 905
2017
Q4
$5.52M Sell
2,015,353
-621,052
-24% -$1.7M 0.01% 1022
2017
Q3
$8.94M Buy
2,636,405
+655,420
+33% +$2.22M 0.01% 765
2017
Q2
$4.89M Buy
1,980,985
+146,471
+8% +$362K 0.01% 1011
2017
Q1
$4.17M Buy
1,834,514
+362,325
+25% +$823K 0.01% 1066
2016
Q4
$3.12M Buy
1,472,189
+867,395
+143% +$1.84M 0.01% 1198
2016
Q3
$2.03M Sell
604,794
-51,804
-8% -$174K ﹤0.01% 1370
2016
Q2
$2.06M Sell
656,598
-547,620
-45% -$1.72M ﹤0.01% 1422
2016
Q1
$4.01M Buy
1,204,218
+531,852
+79% +$1.77M 0.01% 1073
2015
Q4
$2.38M Buy
+672,366
New +$2.38M ﹤0.01% 1315
2015
Q3
Sell
-10,895
Closed -$70K 2902
2015
Q2
$70K Sell
10,895
-89,600
-89% -$576K ﹤0.01% 2558
2015
Q1
$707K Buy
100,495
+56,782
+130% +$399K ﹤0.01% 1923
2014
Q4
$337K Buy
+43,713
New +$337K ﹤0.01% 2162
2014
Q1
Sell
-47,456
Closed -$401K 2812
2013
Q4
$401K Buy
+47,456
New +$401K ﹤0.01% 2029